Inadequate glycaemic control and antidiabetic therapy among inpatients with type 2 diabetes in Guangdong Province of China

查看全文 作　　者：BI [1,2]Yan;YAN Jin-[1]hua;LIAO Zhi-[1]hong;LI Yan-[1]bing;ZENG Long-[2]yi;TANG Kuan-[1]xiao;XUE Yao-[3]ming;YANG Hua-[4]zhang;LI [5]Lu;CAI De-[6]hong;WU [7]Ge;ZHANG [8]Fan;LIN Shao-[9]da;XIAO Zheng-[10]hua;ZHU Da-[11]long;WENG Jian-[2]ping 机构地区：[1]Department of Endocrinology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China;[2]Department of Endocrinology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China;[3]Department of Endocrinology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China;[4]Department of Endocrinology, Guangdong Provincial People's Hospital, Guangzhou, Guangdong 510080, China;[5]Department of Endocrinology, Shenzhen People's Hospital, Medical College of Jinan University, Shenzhen, Guangdong 518020, China;[6]Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China;[7]Department of Endocrinology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China;[8]Department of Endocrinology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China;[9]Department of Endocrinology, First Affiliated Hospital of Medical College of Shantou University, Shantou, Guangdong 515041, China;[10]Department of Endocrinology, Guangzhou First Municipal People's Hospital, Guangzhou, Guangdong 510180, China;[11]Department of Endocrinology, Drum Tower Hospital Affiliated to Medical College of Nanjing University, Nanjing, Jiangsu 210008, China 出　　处：《Chinese Medical Journal》索引2008年第8期,共5页 摘　　要：背景糖尿病 mellitus 在调查的 China.We 在最近的年里变得流行在来自在广东省教医院的十所大学的类型 2 糖尿病的住院病人之中的多糖症和不适当的 glycaemic 控制的流行,中国。当 HbA1c() 6.5%.Therapeutic 政体包括了没有干预,在糖尿病的病人的方法不适当的 glycaemic 控制被定义,生活方式仅仅,口头的 antiglycemic 代理人(OA ) ,加 OA (insulin+OA ) 的胰岛素,或胰岛素仅仅。Antidiabetic 管理包括了 monotherapy,两倍治疗,三元组或四倍的治疗。在有已知的历史的 493 个糖尿病的住院病人之中的结果, 75%had HbA1c6.5%.Inadequate 葡萄糖控制率更经常比在 OA 政体(71%)( PO.001 )上在 insulin+OA 政体(97%)上在病人被看见,并且在联合治疗(81%-96%)上的病人更经常比 monotherapy (75%)( P0.05 ),胰岛素上的 .Patients 由吝啬的 HbA1c , glycemic 控制率,糖尿病持续时间, microvascular 复杂并发症,和 BMI ( P0.01 )在 OA 上与病人显著地不同。这研究看了类型 2 糖尿病的病人的那 glycaemic 控制的结论为胰岛素的收到的胰岛素和开始时间通常是谁的病人败坏了 delayed.It 依赖临床医生从传统的逐步的治疗搬到更活跃、早的联合 antidiabetic 治疗提供更好的葡萄糖控制。 关 键 词：中国 广东 2型糖尿病 血糖控制 抗糖尿病药物治疗 住院病人